Literature DB >> 12003846

QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability.

Velislav N Batchvarov1, Azad Ghuran, Peter Smetana, Katerina Hnatkova, Monica Harries, Polychronis Dilaveris, A John Camm, Marek Malik.   

Abstract

Recently, it was demonstrated that the QT-RR relationship pattern varies significantly among healthy individuals. We compared the intra- and interindividual variations of the QT-RR relationship. Twenty-four-hour 12-lead digital electrocardiograms (ECGs; SEER MC, GE Marquette; 10-s ECG recorded every 30 s) were obtained at baseline and after 24 h, 1 wk, and 1 mo in 75 healthy subjects (42 women, 33 men, age 27.9 +/- 9.6 vs. 26.8 +/- 7.5 yr, P = not significant). QT interval was measured automatically in each ECG by six different algorithms, and the mean of the six measurements was analyzed. In each recording of each individual, QT-RR relationship was assessed by 10 different regression models including linear (QT = beta + alpha x RR) and parabolic (QT = beta x RR(alpha)) models. Standard deviations (SDs) of regression parameters alpha and beta of consecutive recordings of each individual were compared with SD of the individual means. Intrasubject stability and interindividual variability were further tested by ANOVA. With all models, intraindividual SDs of the regression parameters were highly significantly smaller than SD of individual means (P < 10(-5)-10(-9)). The intrasubject stability was further confirmed by ANOVA (P < 10(-19)-10(-30)). The QT-RR relationship exhibits substantial intersubject variability as well as a high intrasubject stability. This has practical implications for a precise estimation of the heart rate-corrected QT interval in which optimized subject-specific rate correction formulas should be used.

Entities:  

Mesh:

Year:  2002        PMID: 12003846     DOI: 10.1152/ajpheart.00860.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  51 in total

1.  Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.

Authors:  Marek Malik
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

2.  Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men.

Authors:  Abdullah Dogan; Ercan Tunc; Ercan Varol; Mehmet Ozaydin; Mustafa Ozturk
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

Review 3.  Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose.

Authors:  Geoffrey K Isbister; Lena E Friberg; Stephen B Duffull
Journal:  Intensive Care Med       Date:  2006-05-10       Impact factor: 17.440

Review 5.  The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships.

Authors:  A A Fossa
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

Review 6.  Thorough QT Studies: Questions and Quandaries.

Authors:  Marek Malik; Christine E Garnett; Joanne Zhang
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

7.  Drug-induced changes in the T-wave morphology.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Recovery of heart rate variability and ventricular repolarization indices following exercise.

Authors:  Marc K Lahiri; Alexandru Chicos; Dan Bergner; Jason Ng; Smirti Banthia; Norman C Wang; Haris Subačius; Alan H Kadish; Jeffrey J Goldberger
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

Review 9.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

10.  Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.

Authors:  P Chaikin; M S Gillen; M Malik; H Pentikis; G R Rhodes; D J Roberts
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.